BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2827345)

  • 1. [Imported leishmaniasis of dogs: clinical aspects, diagnosis and therapy with Na stibogluconate (Pentostam)].
    Reusch C; Reiter I
    Tierarztl Prax; 1987; 15(3):305-10. PubMed ID: 2827345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
    Pasa S; Toz SO; Voyvoda H; Ozbel Y
    Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
    Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
    Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leishmaniasis in dogs. Clinical course of infection, diagnosis and therapy trials following experimental infection of beagles with Leishmania donovani (Calcutta strain)].
    Reiter I; Kretzschmar A; Boch J; Krampitz H
    Berl Munch Tierarztl Wochenschr; 1985 Feb; 98(2):40-4. PubMed ID: 2983657
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis in a dog from Maryland.
    Eddlestone SM
    J Am Vet Med Assoc; 2000 Dec; 217(11):1686-8, 1659. PubMed ID: 11110461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of Kenyan kala-azar to treatment with sodium stibogluconate.
    Rees PH; Kager PA; Wellde BT; Hockmeyer WT
    Am J Trop Med Hyg; 1984 May; 33(3):357-61. PubMed ID: 6329010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of allopurinol to treat visceral leishmaniosis in a dog.
    Lester SJ; Kenyon JE
    J Am Vet Med Assoc; 1996 Aug; 209(3):615-7. PubMed ID: 8755981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 11. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 12. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 14. Leishmaniasis recidivans treated with sodium stibogluconate.
    Schewach-Millet M; Fisher BK; Semah D
    Cutis; 1981 Jul; 28(1):67-8, 77, 84 passim. PubMed ID: 6266776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
    Steuber S; Moritz A; Schirrmann I; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of allopurinol and pentostam in the treatment of visceral leishmaniasis.
    Tobaigy M; Mejer J; Peitersen B; Ansari M; Poll P
    Adv Exp Med Biol; 1986; 195 Pt A():471-3. PubMed ID: 3014837
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1985 May; 33(5):379-80. PubMed ID: 2995305
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
    Black CD; Watson GJ; Ward RJ
    Trans R Soc Trop Med Hyg; 1977; 71(6):550-2. PubMed ID: 204085
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and serological aspects of visceral leishmaniasis in northeast Brazilian dogs naturally infected with Leishmania chagasi.
    Almeida MA; Jesus EE; Sousa-Atta ML; Alves LC; Berne ME; Atta AM
    Vet Parasitol; 2005 Feb; 127(3-4):227-32. PubMed ID: 15710523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study.
    Rougier S; Vouldoukis I; Fournel S; Pérès S; Woehrlé F
    Vet Parasitol; 2008 May; 153(3-4):244-54. PubMed ID: 18337012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.